Showing results (2331-2340 of 2,591) with videos related to

Sort By:
Pageof 260
Molecular Oncology|March 13, 2013
Genetically engineered mouse models of PI3K signaling in breast cancerSjoerd Klarenbeek, Martine H van Miltenburg, Jos Jonkers
Molecular Oncology|March 14, 2013
Genetically engineered mouse models of prostate cancerMaxime Parisotto, Daniel Metzger
Molecular Oncology|February 5, 2013
Profiling pathway-specific novel therapeutics in preclinical assessment for central nervous system atypical teratoid rhabdoid tumors (CNS ATRT): favorable activity of targeting EGFR- ErbB2 signaling with lapatinibAnjali Singh, Xueqing Lun, Aarthi Jayanthan, et al.
Molecular Oncology|September 10, 2013
c-Ski activates cancer-associated fibroblasts to regulate breast cancer cell invasionLiyang Wang, Yixuan Hou, Yan Sun, et al.
Molecular Oncology|September 10, 2013
Aberrant signalling by protein kinase CK2 in imatinib-resistant chronic myeloid leukaemia cells: biochemical evidence and therapeutic perspectivesChristian Borgo, Luca Cesaro, Valentina Salizzato, et al.
Molecular Oncology|September 10, 2013
Targeted serum miRNA (TSmiR) test for diagnosis and follow-up of (testicular) germ cell cancer patients: a proof of principleAd J M Gillis, Martin A Rijlaarsdam, Ronak Eini, et al.
Molecular Oncology|July 22, 2014
Integrative genomic and transcriptomic characterization of papillary carcinomas of the breastSalvatore Piscuoglio, Charlotte K Y Ng, Luciano G Martelotto, et al.
Molecular Oncology|May 4, 2013
Tumor suppressors status in cancer cell line EncyclopediaDmitriy Sonkin, Mehedi Hassan, Denis J Murphy, et al.
Molecular Oncology|July 31, 2014
miR-206 inhibits cell migration through direct targeting of the actin-binding protein coronin 1C in triple-negative breast cancerJun Wang, Efrosini Tsouko, Philip Jonsson, et al.
Molecular Oncology|August 5, 2014
Tumour heterogeneity and the evolution of polyclonal drug resistanceRebecca A Burrell, Charles Swanton
Pageof 260